Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX2BBL
|
||||
| Drug Name |
(S)-N-(2,3-dichlorobenzyl)-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amine
|
||||
| Synonyms |
CHEMBL245880
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C16H22Cl2N2O
|
||||
| Canonical SMILES |
Clc1cccc(CN(C2CCOCC2)[C@H]3CCNC3)c1Cl
|
||||
| InChI |
InChI=1S/C16H22Cl2N2O/c17-15-3-1-2-12(16(15)18)11-20(14-4-7-19-10-14)13-5-8-21-9-6-13/h1-3,13-14,19H,4-11H2/t14-/m0/s1
|
||||
| InChIKey |
PIMIZGGCAMLEJJ-AWEZNQCLSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1B receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.